Bang Heejung, Zhao Hongwei
Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, California, USA.
J Biopharm Stat. 2012;22(2):401-15. doi: 10.1080/10543406.2010.544437.
In cost-effectiveness analysis, interest could lie foremost in the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental cost to the incremental benefit of two competing interventions. The average cost-effectiveness ratio (ACER) is the ratio of the cost to benefit of an intervention without reference to a comparator. A vast literature is available for statistical inference of the ICERs, but limited methods have been developed for the ACERs, particularly in the presence of censoring. Censoring is a common feature in prospective studies, and valid analyses should properly adjust for censoring in cost as well as in effectiveness. In this article, we propose statistical methods for constructing a confidence interval for the ACER from censored data. Different methods-Fieller, Taylor, bootstrap-are proposed, and through simulation studies and data analysis, we address the performance characteristics of these methods.
在成本效益分析中,人们可能首先关注增量成本效益比(ICER),它是两种相互竞争干预措施的增量成本与增量效益之比。平均成本效益比(ACER)是一项干预措施的成本与效益之比,不涉及比较对象。关于ICER的统计推断已有大量文献,但针对ACER的方法开发有限,尤其是在存在删失的情况下。删失是前瞻性研究的一个常见特征,有效的分析应在成本和效益方面对删失进行适当调整。在本文中,我们提出了从删失数据构建ACER置信区间的统计方法。我们提出了不同的方法——菲勒方法、泰勒方法、自助法——并通过模拟研究和数据分析,探讨了这些方法的性能特征。